Mutation of DNA Polymerase Β R137Q Results in Retarded Embryo Development Due to Impaired DNA Base Excision Repair in Mice
Feiyan Pan,Jing Zhao,Ting Zhou,Zhihui Kuang,Huifang Dai,Huan Wu,Hongfang Sun,Xiaolong Zhou,Xuping Wu,Zhigang Hu,Lingfeng He,Binghui Shen,Zhigang Guo
DOI: https://doi.org/10.1038/srep28614
IF: 4.6
2016-01-01
Scientific Reports
Abstract:DNA polymerase β (Pol β), a key enzyme in the DNA base excision repair (BER) pathway, is pivotal in maintaining the integrity and stability of genomes. One Pol β mutation that has been identified in tumors, R137Q (arginine to glutamine substitution), has been shown to lower polymerase activity, and impair its DNA repair capacity. However, the exact functional deficiency associated with this polymorphism in living organisms is still unknown. Here, we constructed Pol β R137Q knock-in mice, and found that homozygous knock-in mouse embryos were typically small in size and had a high mortality rate (21%). These embryonic abnormalities were caused by slow cell proliferation and increased apoptosis. In R137Q knock-in mouse embryos, the BER efficiency was severely impaired, which subsequently resulted in double-strand breaks (DSBs) and chromosomal aberrations. Furthermore, R137Q mouse embryo fibroblasts (MEFs) were more sensitive to DNA-damaging reagents, such as methyl methanesulfonate (MMS) and H2O2. They displayed a higher percentage of DSBs, and were more likely to undergo apoptosis. Our results indicate that R137 is a key amino acid site that is essential for proper Pol β functioning in maintaining genomic stability and embryo development.